Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

18. Novembre 2024

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1757


	Articles 1 - 20 / 35124

	Association of B cells and the risk of Esophageal cancer: a bidirectional two-sample mendelian randomization study. BMC Cancer Guo J, Si G, Song X, Si F. PMID: 39550560 [PubMed - indexed for MEDLINE]
	Oesophageal cancer. Lancet Yang H, Wang F, Hallemeier CL, Lerut T, Fu J. PMID: 39550174 [PubMed - indexed for MEDLINE]
	Prognostic value of the cholesterol-dependent nutritional prognostic index in patients receiving adjuvant chemotherapy after radical esophageal cancer treatment. Eur J Med Res Long Y, Shi R. PMID: 39548556 [PubMed - indexed for MEDLINE]
	Serum urea concentration and risk of 16 site-specific cancers, overall cancer, and cancer mortality in individuals with metabolic syndrome: a cohort study. BMC Med Wu E, Wei GF, Li Y, Du MK, Ni JT. PMID: 39548477 [PubMed - indexed for MEDLINE]
	Effect of Behavioral Activation on Stigma and Quality of Life in Patients With Advanced Esophageal and Gastric Cancer: A Randomized Controlled Trial. Psychooncology Huang R, Ge H, Nie G, Li A, Liu L, Cheng L, Zhang M, Cheng H. PMID: 39547955 [PubMed - indexed for MEDLINE]
	Community prevention and standardized clinical treatment jointly improve cancer outcome: Real-world evidence from an esophageal cancer patient cohort study. Sci Bull (Beijing) Ke J, Liu F, Yang W, Xu R, Chen L, Yang W, He Y, Liu Z, Hou B, Zhang L, Lin M, Zhang L, Zhang F, Cai F, Xu H, Liu M, Liu Y, Pan Y, He Z, Ke Y. PMID: 39547907 [PubMed - as supplied by publisher]
	Multimodality deep learning radiomics predicts pathological response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma. Insights Imaging Liu Y, Wang Y, Hu X, Wang X, Xue L, Pang Q, Zhang H, Ma Z, Deng H, Yang Z, Sun X, Men Y, Ye F, Men K, Qin J, Bi N, Zhang J, Wang Q, Hui Z. PMID: 39546168 [PubMed]
	Clinical effectiveness and safety of Camrelizumab immunotherapy in treating advanced esophageal carcinoma. Am J Transl Res Pan Y, Ding J. PMID: 39544791 [PubMed]
	Risk factor analysis and predictive model construction for postoperative bleeding in early esophageal cancer. Am J Transl Res Huang L, Li J, Zheng Y, Lu R, Yu L. PMID: 39544777 [PubMed]
	Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial. Clin Cancer Res Wang X, Kang X, Zhang R, Xue L, Xu J, Zhao X, Ou Q, Yu N, Feng G, Li J, Zheng Z, Chen X, Wang Z, Zheng Q, Li Y, Qin J, Bi N, Li Y. PMID: 39544026 [PubMed - indexed for MEDLINE]
	Integrating (18)F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer. BMC Cancer Zhou Y, Zhou J, Cai X, Ge S, Sang S, Yang Y, Zhang B, Deng S. PMID: 39543534 [PubMed - indexed for MEDLINE]
	Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study. Ann Oncol Lordick F, Mauer ME, Stocker G, Cella CA, Ben-Aharon I, Piessen G, Wyrwicz L, Al-Haidari G, Fleitas-Kanonnikoff T, Boige V, Obermannová RL, Martens UM, Gomez-Martin C, Thuss-Patience P, Arrazubi V, Avallone A, Shiu KK, Artru P, Brenner B, Sanchez CB, Chau I, Lorenzen S, Daum S, Sinn M, Merelli B, van Grieken NCT, Nilsson M, Collienne M, Giraut A, Smyth E. PMID: 39542422 [PubMed - as supplied by publisher]
	Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation. Mol Diagn Ther Houvast RD, van Duijvenvoorde M, Thijse K, de Steur WO, de Geus-Oei LF, Crobach ASLP, Burggraaf J, Vahrmeijer AL, Kuppen PJK. PMID: 39541080 [PubMed - as supplied by publisher]
	[Small cell neuroendocrine carcinoma of the oesophagus: case report and literature review]. Rev Gastroenterol Peru Lipiejko J, Moratorio I, Canavesi A. PMID: 39538402 [PubMed - indexed for MEDLINE]
	(18)Fluorodeoxyglucose positron emission tomography ((18)F-FDG PET)-derived tumoral and peritumoral radiomic parameters can predict pathological subtype and survival in esophageal carcinoma. Clin Radiol Kucuker KA, Aksu A, Alacacioglu A, Turgut B. PMID: 39536596 [PubMed - as supplied by publisher]
	Impact of time from diagnosis to endoscopic submucosal dissection on curability in superficial esophageal squamous cell carcinoma. DEN Open Sato D, Sasabe M, Mitsui T, Furue Y, Yoshii T, Hara H, Oka D, Fukuda T, Yoda Y. PMID: 39534405 [PubMed]
	Decoding the role of FOXP3 in esophageal cancer: Underlying mechanisms and therapeutic implications. Biochim Biophys Acta Rev Cancer Wang Y, Xue L. PMID: 39532205 [PubMed - as supplied by publisher]
	The onset characteristics and prognosis of patients with radiation-associated second primary malignancy: a pancancer study in the US SEER cancer registries. Transl Cancer Res Zhang Y, Wei R, Bai L, Jiao S, Milano MT, Liu H, Wei Z. PMID: 39525022 [PubMed]
	Prognostic significance and risk factors of mediastinal lymph node metastasis in esophagogastric junction cancer: a single-center, retrospective study. Langenbecks Arch Surg Higuchi Y, Maruyama S, Shoda K, Kawaguchi Y, Saito R, Takiguchi K, Izumo W, Nakata Y, Shiraishi K, Furuya S, Amemiya H, Kawaida H, Ichikawa D. PMID: 39535602 [PubMed - indexed for MEDLINE]
	Integrated machine learning developed a prognosis-related gene signature to predict prognosis in oesophageal squamous cell carcinoma. J Cell Mol Med Tang P, Li B, Zhou Z, Wang H, Ma M, Gong L, Qiao Y, Ren P, Zhang H. PMID: 39535375 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 35124

Page 1 de 1757



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité